Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 3
1979 1
1982 4
1983 1
1984 4
1985 1
1986 2
1987 7
1988 5
1989 5
1990 5
1991 2
1992 2
1993 2
1994 2
1995 7
1996 1
1997 5
1998 5
1999 3
2000 4
2001 1
2002 2
2003 7
2004 1
2005 7
2006 5
2007 4
2008 12
2009 8
2010 8
2011 8
2012 6
2013 6
2014 4
2015 2
2016 3
2017 3
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators. Torres VE, et al. N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121377 Free PMC article. Clinical Trial.
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up.
Dahan K, Debiec H, Plaisier E, Cachanado M, Rousseau A, Wakselman L, Michel PA, Mihout F, Dussol B, Matignon M, Mousson C, Simon T, Ronco P; GEMRITUX Study Group. Dahan K, et al. J Am Soc Nephrol. 2017 Jan;28(1):348-358. doi: 10.1681/ASN.2016040449. Epub 2016 Jun 27. J Am Soc Nephrol. 2017. PMID: 27352623 Free PMC article. Clinical Trial.
[Encapsulating peritoneal sclerosis].
Ryckelynck JP, Béchade C, Bouvier N, Ficheux M, Hurault de Ligny B, Lobbedez T. Ryckelynck JP, et al. Nephrol Ther. 2017 Jun;13(4):211-219. doi: 10.1016/j.nephro.2017.01.020. Epub 2017 May 30. Nephrol Ther. 2017. PMID: 28576435 Review. French.
[Peritoneal dialysis].
Ryckelynck JP, Lobbedez T, Hurault de Ligny B. Ryckelynck JP, et al. Nephrol Ther. 2005 Oct;1(4):252-63. doi: 10.1016/j.nephro.2005.06.009. Epub 2005 Sep 8. Nephrol Ther. 2005. PMID: 16895693 Review. French. No abstract available.
Adequacy in peritoneal dialysis.
Ryckelynck JP, Ficheux M, Castrale C, Henri P, Lobbedez T. Ryckelynck JP, et al. Contrib Nephrol. 2012;178:195-199. doi: 10.1159/000337852. Epub 2012 May 25. Contrib Nephrol. 2012. PMID: 22652737 Review.
Peritoneal dialysis and renal transplantation.
Lobbedez T, Lecouf A, Abbadie O, Ficheux M, de Ligny BH, Ryckelynck JP. Lobbedez T, et al. Among authors: ryckelynck jp. Contrib Nephrol. 2009;163:250-256. doi: 10.1159/000223806. Epub 2009 Jun 3. Contrib Nephrol. 2009. PMID: 19494621 Review.
Clinical pharmacokinetics of fluconazole.
Debruyne D, Ryckelynck JP. Debruyne D, et al. Among authors: ryckelynck jp. Clin Pharmacokinet. 1993 Jan;24(1):10-27. doi: 10.2165/00003088-199324010-00002. Clin Pharmacokinet. 1993. PMID: 8448970 Review.
[Why and how to promote peritoneal dialysis?].
Ryckelynck JP, Abbadie O, Castrale C, Lavainne F, Fakhouri F, Lobbedez T. Ryckelynck JP, et al. Presse Med. 2011 Nov;40(11):1053-8. doi: 10.1016/j.lpm.2011.06.021. Epub 2011 Sep 15. Presse Med. 2011. PMID: 21924862 Review. French.
[Peritoneal dialisys].
Ryckelynck JP, Lobbedez T, Castrale C, Ficheux M. Ryckelynck JP, et al. Rev Prat. 2012 Jan;62(1):62-3. Rev Prat. 2012. PMID: 22335069 French. No abstract available.
[Peritoneal dialysis, a first-line treatment?].
Lanot A, Ryckelynck JP. Lanot A, et al. Among authors: ryckelynck jp. Soins. 2018 Jun;63(826):27-30. doi: 10.1016/j.soin.2018.04.008. Soins. 2018. PMID: 29958578 Free article. French.
149 results